Portfolio Update

RNS Number : 4292X

Intl. Biotechnology Trust PLC

21 February 2017

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 31 January 2017

Net Assets	£231m
Net Assets per share	615p
Share price	549p
Total value of unquoted investments	£24m
Total number of portfolio companies	80

Top Ten Holdings

Company Name	% NAV
Incyte	6.6
Gilead	5.9
Celgene	5.8
Regeneron	5.6
Genmab	5.4
Amgen	5.3
Biogen	5.0
Tesaro	4.3
Alexion	3.8
Illumina	3.6
	-----------
Total	51.3

Geographical Allocation	% NAV
US & Canada	86
Europe & UK	14
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	90
Unquoted	10
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	55
Mid Cap =USD1-10BN	24
Small Cap <USD1BN	21
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	42
Orphan	10
CNS	8
Ophthalmology	8
Inflammation	6
Medtech	2
Other	24
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

21 FEBRUARY 2017

 

END

 

 

PFUGCGDDSUDBGRB